Browse By: Country ι Category ι Latest Reports ι Tag

Hepatitis Market Research Reports

Hepatitis C Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
Hepatitis is defined as the inflammation of the liver due to an infection by a virus or other causative organism or toxin. Hepatitis C on the other hand, is primarily as a result of the infection by hepatitis C virus (HCV). With a cure rate between 50%-80%, and no commercially available vaccine as of yet, hepatitis C is considered a deadly disease with a moderate to high infection rate. It is the leading cause for liver transplantation in the U.K and North America.  The transmission of this virus in a majority occurs from injectables drug abuse, as the virus can only be transmitted via blood-to-blood contact. The secondary transmission factors include tattooing, sexual contact, healthcare (blood transfusion, organ transplant) mishaps, and other rare unknown cases. HIV infected indi
Published Date: Apr 2025
Published By: Transparency

Price: $5795
Hepatitis Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization. Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two mont
Published Date: Nov 2020
Published By: Transparency

Price: $5795
Global Hepatitis Vaccines Sales Market Report 2021
Sales, means the sales volume of Hepatitis Vaccines Revenue, means the sales value of Hepatitis Vaccines This report studies sales (consumption) of Hepatitis Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer bioCSL (Seqirus) Protein Sciences Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Hepatitis Vaccines in these regions, from 2011 to 2021 (forecast), like North America China Europe Japan Southeast As
Published Date: Aug 2016
Published By: QYResearch

Price: $4000
China Prophylactic Hepatitis B Virus Vaccines Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prophylactic Hepatitis B Virus Vaccines market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Ups
Published Date: Aug 2016
Published By: QYResearch

Price: $3200
United States Hepatitis Vaccines Market Report 2021
Sales, means the sales volume of Hepatitis Vaccines Revenue, means the sales value of Hepatitis Vaccines This report studies sales (consumption) of Hepatitis Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer bioCSL (Seqirus) Protein Sciences Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Hepatitis Vaccines in each application, can be divided into Medical care Healthy Hospita
Published Date: Aug 2016
Published By: QYResearch

Price: $3800
Global Hepatitis Vaccines Market Research Report 2021
Sales, means the sales volume of Hepatitis Vaccines Revenue, means the sales value of Hepatitis Vaccines This report studies Hepatitis Vaccines in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Sanofi Pasteur Merck Novartis Pfizer bioCSL (Seqirus) Protein Sciences Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Hepatitis Vaccines in these regions, from 2011 to 2021 (forecast), like North America China Europe Japan India Southeast Asia Split by product type, with sales, reven
Published Date: Aug 2016
Published By: QYResearch

Price: $2900
Global Hepatitis A Vaccine Sales Market Report 2021
Sales, means the sales volume of Hepatitis A Vaccine Revenue, means the sales value of Hepatitis A Vaccine This report studies sales (consumption) of Hepatitis A Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering GlaxoSmithKline MERCK SHARP & DOHME CORP SANOFI PASTEUR NORVATIS CRUCELL CHINA ACADEMY OF MEDICAL SCIENCES CHANGCHUN INSTITUTE OF BIOLOGICAL PRODUCTS ZHEJIANG PUKANG CHANGSHENG SINOVAC Shanghai Zerun Biotechnology Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth
Published Date: Aug 2016
Published By: QYResearch

Price: $4000
Europe Prophylactic Hepatitis B Virus Vaccines Sales Market Report 2021
GlaxoSmithKline Merck Sanofi Kaketsuken Dynavax Technologies ... Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in these regions, from 2011 to 2021 (forecast), like Germany France UK Italy Spain Russia Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type 1 Type 2 Type 3 Split by applications, this report focuses on sales, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in each application, can be divided into Application 1 Application 2 Application 3
Published Date: Aug 2016
Published By: QYResearch

Price: $4900
United states Human Hepatitis B Immunoglobulin (IM) Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Hepatitis B Immunoglobulin (IM) market analysis is provided for the United states markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United states major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact in
Published Date: Aug 2016
Published By: QYResearch

Price: $3800
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight’s Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Nonalcoholic Steatohepatitis (NASH) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Nonalcoholic Steatohepatitis (NASH) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Nonalcoholic Steatohepatitis (NASH) till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the
Published Date: Aug 2016
Published By: DelveInsight

Price: $4950
United States Prophylactic Hepatitis B Virus Vaccines Sales Market Report 2021
GlaxoSmithKline Merck Sanofi Kaketsuken Dynavax Technologies ... Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type 1 Type 2 Type 3 Split by applications, this report focuses on sales, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in each application, can be divided into Application 1 Application 2 Application 3
Published Date: Jul 2016
Published By: QYResearch

Price: $3800
China Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, r
Published Date: Jul 2016
Published By: QYResearch

Price: $3200
China Viral Hepatitis and Retrovirus Diagnostic Tests Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Viral Hepatitis and Retrovirus Diagnostic Tests market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact informat
Published Date: Jul 2016
Published By: QYResearch

Price: $3200
China Human Hepatitis B Immunoglobulin (IM) Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Hepatitis B Immunoglobulin (IM) market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstr
Published Date: Jul 2016
Published By: QYResearch

Price: $3200
Europe Human Hepatitis B Immunoglobulin (IM) Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Hepatitis B Immunoglobulin (IM) market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Ups
Published Date: Jul 2016
Published By: QYResearch

Price: $3600
Global Prophylactic Hepatitis B Virus Vaccines Sales Market Report 2021
GlaxoSmithKline Merck Sanofi Kaketsuken Dynavax Technologies … Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in these regions, from 2011 to 2021 (forecast), like North America China Europe Japan Southeast Asia India Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type 1 Type 2 Type 3 Split by applications, this report focuses on sales, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in each application, can be divided into Application 1 Application 2 Application 3
Published Date: Jul 2016
Published By: QYResearch

Price: $4000
Global and China Hepatitis A Vaccine Sales Market Report to 2020
This report studies Hepatitis A Vaccine in Global and China market, focuses on top manufacturers in global and China market, involving Hepatitis A Vaccine price of each type, production, revenue and market share for each manufacturer. 
Published Date: Jul 2016
Published By: QYResearch

Price: $2900
Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016
Summary Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non-Alcoholic Steatohepatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Non-Alcoholic Steatohepatitis and features dormant and discontinued projects. Global Markets D
Published Date: Jul 2016
Published By: Global Markets Direct

Price: $2000
United States Hepatitis A Vaccine Sales Market Report 2021
This report studies sales (consumption) of Hepatitis A Vaccine in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Published Date: Jul 2016
Published By: QYResearch

Price: $3800
Global Human Hepatitis B Immunoglobulin (IM) Consumption 2016 Market Research Report
First, the report provides a basic overview of the Human Hepatitis B Immunoglobulin (IM) industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Published Date: Jul 2016
Published By: QYResearch

Price: $4000
Europe Viral Hepatitis and Retrovirus Diagnostic Tests Industry 2016 Market Research Report
The Viral Hepatitis and Retrovirus Diagnostic Tests market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Jul 2016
Published By: QYResearch

Price: $3600
Global Prophylactic Hepatitis B Virus Vaccines Market Research Report 2021
GlaxoSmithKline Merck Sanofi Kaketsuken Dynavax Technologies Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in these regions, from 2011 to 2021 (forecast), like North America China Europe Japan India Southeast Asia Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into Type 1 Type 2 Type 3 Split by application, this report focuses on sales, market share and growth rate of Prophylactic Hepatitis B Virus Vaccines in each application, can be divided into Application 1 Application 2 Application 3
Published Date: Jul 2016
Published By: QYResearch

Price: $2900
Global Human Hepatitis B Immunoglobulin (IM) Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Hepatitis B Immunoglobulin (IM) market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specific
Published Date: Jul 2016
Published By: QYResearch

Price: $2800
United States Alcoholic Hepatitis Drugs Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Alcoholic Hepatitis Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. U
Published Date: Jul 2016
Published By: QYResearch

Price: $3800
Global Viral Hepatitis and Retrovirus Diagnostic Tests Consumption 2016 Market Research Report
First, the report provides a basic overview of the Viral Hepatitis and Retrovirus Diagnostic Tests industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Viral Hepatitis and Retrovirus Diagnostic Tests market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Viral Hepatitis and Retrovirus Diagnostic Tests market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and comp
Published Date: Jul 2016
Published By: QYResearch

Price: $4000
Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis on Hepatitis B Virus Core Antigen (HBcAg) targeted pipeline therapeutics. The report provides comprehensive information on the Hepatitis B Virus Core Antigen (HBcAg), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Hepatitis B Virus Core Antigen (HBcAg) targeted therapeutics development and features dormant a
Published Date: Jun 2016
Published By: Global Markets Direct

Price: $3500
Europe Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, rev
Published Date: Jun 2016
Published By: QYResearch

Price: $3600
United States Viral Hepatitis and Retrovirus Diagnostic Tests Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Viral Hepatitis and Retrovirus Diagnostic Tests market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and cont
Published Date: Jun 2016
Published By: QYResearch

Price: $3800
Hepatitis C Virus (HCV) Envelope Protein E2 - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis C Virus (HCV) Envelope Protein E2 - Pipeline Review, H1 2016’, provides in depth analysis on Hepatitis C Virus (HCV) Envelope Protein E2 targeted pipeline therapeutics. The report provides comprehensive information on the Hepatitis C Virus (HCV) Envelope Protein E2 , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Hepatitis C Virus (HCV) Envelope Protein E2 targeted therapeutics development a
Published Date: Jun 2016
Published By: Global Markets Direct

Price: $3500
United States Non-Alcoholics Steatohepatitis Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Non-Alcoholics Steatohepatitis market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact informati
Published Date: Jun 2016
Published By: QYResearch

Price: $3800
China Hepatitis B Vaccine Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B Vaccine market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials
Published Date: Jun 2016
Published By: QYResearch

Price: $3200
Global Viral Hepatitis and Retrovirus Diagnostic Tests Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Viral Hepatitis and Retrovirus Diagnostic Tests market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture an
Published Date: Jun 2016
Published By: QYResearch

Price: $2800
Global Nonalcoholic Steatohepatitis Therapeutics Consumption 2016 Market Research Report
First, the report provides a basic overview of the Nonalcoholic Steatohepatitis Therapeutics industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Nonalcoholic Steatohepatitis Therapeutics market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Nonalcoholic Steatohepatitis Therapeutics market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the
Published Date: Jun 2016
Published By: QYResearch

Price: $4000
Global Alcoholic Hepatitis Drugs Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Alcoholic Hepatitis Drugs market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capac
Published Date: Jun 2016
Published By: QYResearch

Price: $2800
Global Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) Consumption 2016 Market Research Report
First, the report provides a basic overview of the Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and
Published Date: Jun 2016
Published By: QYResearch

Price: $4000
Global Non-Alcoholics Steatohepatitis Consumption 2016 Market Research Report
First, the report provides a basic overview of the Non-Alcoholics Steatohepatitis industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Non-Alcoholics Steatohepatitis market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Non-Alcoholics Steatohepatitis market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major le
Published Date: Jun 2016
Published By: QYResearch

Price: $4000
United States Nonalcoholic Steatohepatitis Therapeutics Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nonalcoholic Steatohepatitis Therapeutics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contac
Published Date: Jun 2016
Published By: QYResearch

Price: $3800
Global Non-Alcoholic Steatohepatitis Clinical Trials Market Professional Survey Report 2016
Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India The players list (Partly, Players you are interested in can also be added) Bristol-Myers Squibb AstraZeneca Eli Lilly Roche GSK Novartis Pfizer Sanofi Bayer Celgene With 10 top producers. Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc. More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
Published Date: Jun 2016
Published By: QYResearch

Price: $3500
Global Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company p
Published Date: Jun 2016
Published By: QYResearch

Price: $2800
Global Non-Alcoholics Steatohepatitis Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Non-Alcoholics Steatohepatitis market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification,
Published Date: Jun 2016
Published By: QYResearch

Price: $2800
Global Hepatitis B Vaccine Market Professional Survey Report 2016
Mainly covers the following product types The segment applications including Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India The players list (Partly, Players you are interested in can also be added) GSK Merck Sanofi-Pasteur Novartis BE CSL Behring LG Life Sciences Crucell Berna TIANTAN BIO BIO KANGTAI Hissen NCPC GeneTech HUALAN BIO With no less than 15 top producers. Data including (both global and regions): Market Size (both volume - K Units and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc. More detailed information, please refer to the attachment
Published Date: Jun 2016
Published By: QYResearch

Price: $3500
Global Nonalcoholic Steatohepatitis Therapeutics Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nonalcoholic Steatohepatitis Therapeutics market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and spec
Published Date: Jun 2016
Published By: QYResearch

Price: $2800
Global Hepatitis A Vaccine Market Professional Survey Report 2016
Mainly covers the following product types The segment applications including Segment regions including (the separated region report can also be offered) USA China Europe South America Japan Africa The players list (Partly, Players you are interested in can also be added) GlaxoSmithKline Merck Sharp & Dohme Corp SANOFI PASTEUR S.A Norvatis Crucell Switzerland AG(Berna+Crucell) China Academy of Medical Sciences Changchun Institute of Biological Products Zhejiang Pukang ChangSheng Sinovac Shanghai Zerun Biotechnology With no less than 15 top producers. Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/U
Published Date: Jun 2016
Published By: QYResearch

Price: $3500
Hepatitis B - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H1 2016’, provides an overview of the Hepatitis B pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis B, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis B and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: May 2016
Published By: Global Markets Direct

Price: $2000
Global Hepatitis B virus core antibody diagnostic kits (enzyme-linked immunosorb) Market Professional Survey Report 2016
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
Published Date: May 2016
Published By: QYResearch

Price: $3500
Global Hepatitis vaccine Market Professional Survey Report 2016
Mainly covers the following product types A Hepatitis B vaccine Hepatitis A vaccine Hepatitis B vaccine The segment applications including Hospital use Home use Segment regions including (the separated region report can also be offered) USA China UK France Switzerland Japan The players list (Partly, Players you are interested in can also be added) GSK Wyeth Chengdu Institute NOVARTIS Pfizer Merck Abbott Laboratories TianTan HUALAN Beijing Kexing Chengdu Institute Merck Sharp & Dohme Sanofi Pasteur Aventis Pasteur S.A. Takeda Pharmaceutical BernaBiotech Crucell Changchun Changsheng Changchun Institute MSD Shanghai Institute Dalian Hanxin Shanghai Zerun
Published Date: May 2016
Published By: QYResearch

Price: $3500
Global Hepatitis B Immune Globulin Market Professional Survey Report 2016
Mainly covers the following product types injection Freeze-dried powder The segment applications including Accidental infection of people infants born to mothers with hepatitis B surface antigen (HBsAg) positive Hepatitis B virus carriers of hepatitis B patients and close contacts Segment regions including (the separated region report can also be offered) USA China UK Japan Switzerland Italy Spain Australia The players list (Partly, Players you are interested in can also be added) Baxter CSL Grifols Octapharma BPL Kedrion Mitsubishi Tanabe CBPO RAAS Hualan Bio Beijing Huawang Guangdong Lihui Beijing Wantai Shenyang Huimin Sichuan Yuandashuyang Shantou Weilun Changchun In
Published Date: May 2016
Published By: QYResearch

Price: $3500
Global Human Hepatitis B Immunoglobulin Consumption 2016 Market Research Report
First, the report provides a basic overview of the Human Hepatitis B Immunoglobulin industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Human Hepatitis B Immunoglobulin market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Human Hepatitis B Immunoglobulin market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global ma
Published Date: May 2016
Published By: QYResearch

Price: $4000
Global Non-alcoholic Steatohepatitis Market 2016-2020
NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of unknown etiology and is asymptomatic in nature during its initial stages, resulting in late diagnosis. Conditions such as obesity, diabetes, hyperlipidemia, insulin resistance, and toxicity by drugs such as amiodarone, tamoxifen, and perhexiline maleate can cause NASH. Technavio’s analysts forecast the global NASH market to grow at a CAGR of 24.58% during the period 2016-2020. Covered in this report The report covers the present sc
Published Date: May 2016
Published By: Technavio

Price: $2500
Global Hepatitis Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Hepatitis A - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H1 2016’, provides an overview of the Hepatitis A pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis A, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
United States Human Hepatitis B Immunoglobulin Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Hepatitis B Immunoglobulin market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact informa
Published Date: Apr 2016
Published By: QYResearch

Price: $3800
Hepatitis D - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H1 2016’, provides an overview of the Hepatitis D pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis D, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Hepatitis C - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe coveri
Published Date: Apr 2016
Published By: Global Markets Direct

Price: $2000
Nonalcoholic Steatohepatitis Therapeutics Market (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2025
Nonalcoholic fatty liver disease (NAFLD) is a disorder categorized by excess fat in the liver of people who drink little to no alcohol.
Published Date: Apr 2016
Published By: Transparency

Price: $5795
Global Human Hepatitis B Immunoglobulin Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
Published Date: Apr 2016
Published By: QYResearch

Price: $2800
Global and Chinese Hepatitis B Immunoglobulin Industry, 2016 Market Research Report
Published Date: Apr 2016
Published By: Prof Research

Price: $2800
Hepatitis A Global Clinical Trials Review, H1, 2016
Summary GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, H1, 2016" provides an overview of Hepatitis A clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis A. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial
Published Date: Mar 2016
Published By: GlobalData

Price: $2500
Alcoholic Hepatitis - Pipeline Review, H1 2016
Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H1 2016’, provides an overview of the Alcoholic Hepatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alcoholic Hepatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. Global Markets Direct’s report features investigationa
Published Date: Mar 2016
Published By: Global Markets Direct

Price: $2000
Global Hepatitis C Virus (HCV) Market Report: 2016 Edition
​Hepatitis C Virus (HCV) is an infection which affects the liver which may lead to serious consequences if not taken care of. It spreads through infected blood transfusions and poorly sterilized medical equipments. The number of patients has increased significantly because its symptoms take time to be recognized before the patient progresses towards a clinically visible liver damage which worsens the situation since it may lead to liver damage or even failure. 
Published Date: Mar 2016
Published By: Koncept Analytics

Price: $800
Hepatitis Drugs Companies in China
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products. This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, ind
Published Date: Mar 2016
Published By: Asia Market Information & Development Company

Price: $1800
Hepatitis Drugs Industry Forecasts - China Focus
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products. This new study focuses on industry trends and forecasts with historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazi
Published Date: Mar 2016
Published By: Asia Market Information & Development Company

Price: $1000
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2016
​Global Markets Directs, Non-Alcoholic Steatohepatitis Pipeline Review, H1 2016, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape.
Published Date: Feb 2016
Published By: Global Markets Direct

Price: $2000
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2016
Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2016" provides an overview of Non-Alcoholic Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Alcoholic Steatohepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical
Published Date: Feb 2016
Published By: GlobalData

Price: $2500
United States Hepatitis B Vaccine Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B Vaccine market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstrea
Published Date: Feb 2016
Published By: QYResearch

Price: $3800
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Size Forecast-2020
DelveInsight’s “Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Nonalcoholic Steatohepatitis (NASH) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan.
Published Date: Feb 2016
Published By: DelveInsight

Price: $4950
Europe Hepatitis A Vaccine Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis A Vaccine market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw material
Published Date: Jan 2016
Published By: QYResearch

Price: $3600
Global Hepatitis B Vaccine Consumption 2016 Market Research Report
First, the report provides a basic overview of the Hepatitis B Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Hepatitis B Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Hepatitis B Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with infor
Published Date: Jan 2016
Published By: QYResearch

Price: $4000
Global Hepatitis A Vaccine Consumption 2016 Market Research Report
First, the report provides a basic overview of the Hepatitis A Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Hepatitis A Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Hepatitis A Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focuses on global major leading industry players with infor
Published Date: Jan 2016
Published By: QYResearch

Price: $4000
Global Hepatitis B Vaccine Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B Vaccine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, p
Published Date: Jan 2016
Published By: QYResearch

Price: $2800
Global Hepatitis A Vaccine Industry 2016 Market Research Report
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis A Vaccine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Published Date: Jan 2016
Published By: QYResearch

Price: $2800
Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024
Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths occurred worldwide. Available treatment for chronic hepatitis B focuses on viral suppression, and include oral nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN). The two therapy classes have distinctiv
Published Date: Jan 2016
Published By: GlobalData

Price: $6995
Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024
Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths occurred worldwide. Available treatment for chronic hepatitis B focuses on viral suppression, and include oral nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN). The two therapy classes have distinctiv
Published Date: Jan 2016
Published By: GlobalData

Price: $4995
Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024
Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths occurred worldwide. Available treatment for chronic hepatitis B focuses on viral suppression, and include oral nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN). The two therapy classes have distinctiv
Published Date: Jan 2016
Published By: GlobalData

Price: $4995
Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024
Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths occurred worldwide. Available treatment for chronic hepatitis B focuses on viral suppression, and include oral nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN). The two therapy classes have distinctiv
Published Date: Jan 2016
Published By: GlobalData

Price: $4995
Hepatitis B Virus (HBV) Therapeutics - Current and Future Players
Summary GlobalData has released its pharma report, “Hepatitis B Virus (HBV) Therapeutics - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market. The report identifies and analyses the key companies shaping and driving the global HBV market. The report provides insight into the competitive HBV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts. *This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Scope - Investigation of current and future market competit
Published Date: Jan 2016
Published By: GlobalData

Price: $2995
PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024
Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths occurred worldwide. Available treatment for chronic hepatitis B focuses on viral suppression, and include oral nucleos(t)ide analogues (NAs) and pegylated interferon (PEG-IFN). The two therapy classes have distinctiv
Published Date: Jan 2016
Published By: GlobalData

Price: $10995
Hepatitis C Virus (HCV) Protease Inhibitors - Pipeline Insights, 2016
DelveInsight’s, “Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis C Virus (HCV) Protease Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis C Virus (HCV) Protease Inhib
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis C Report is to understand the market and pipeline status of the drugs around the Hepatitis C to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis C. While the leading brands, companies a
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Hepatitis B-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis B Report is to understand the market and pipeline status of the drugs around the Hepatitis B to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis B. While the leading brands, companies a
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
DelveInsight’s Report, “Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis Report is to understand the market and pipeline status of the drugs around the Hepatitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hepatitis. While the leading brands, companies and che
Published Date: Jan 2016
Published By: DelveInsight

Price: $2000
Steatohepatitis-Pipeline Insights, 2016
DelveInsight’s, “ Steatohepatitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Steatohepatitis. DelveInsight’s Report also assesses the Steatohepatitis therapeutics by Mon
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2016
DelveInsight’s, “ Non-Alcoholic Steatohepatitis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Non-Alcoholic Steatohepatitis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Non-Alcoholic Steatohepatitis. DelveInsight’s Report also assess
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis D-Pipeline Insights, 2016
DelveInsight’s, “ Hepatitis D-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis D. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis D. DelveInsight’s Report also assesses the Hepatitis D therapeutics by Monotherapy, Combin
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Hepatitis A-Pipeline Insights, 2016
DelveInsight’s, “ Hepatitis A-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis A. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hepatitis A. DelveInsight’s Report also assesses the Hepatitis A therapeutics by Monotherapy, Combin
Published Date: Jan 2016
Published By: DelveInsight

Price: $1250
Global Recombinant Hepatitis B Vaccine (Hansenula Polymorpha) Market Outlook 2016-2021
This report delivers an extensive overview of Global Recombinant Hepatitis B Vaccine (Hansenula Polymorpha) industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. It also helps the companies to better understand the trends of Soups market to seize opportunities and formulate crucial business strategies. With this report, you will get access to: 1. Market overview including definition, industrial chain (upstream & downstream), manufacturing technology details and the costs analysis from the aspects of raw materials, labor costs and depreciation. 2. Value and volume consumption status and trends of the market, including Global and Ch
Published Date: Dec 2015
Published By: Gen Consulting

Price: $2800
Global Hepatitis B Vaccine Market Report: 2016 Edition
This report delivers an extensive overview of Global Hepatitis B Vaccine industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. It also helps the companies to better understand the trends of Soups market to seize opportunities and formulate crucial business strategies. With this report, you will get access to: 1. Market overview including definition, industrial chain (upstream & downstream), manufacturing technology details and the costs analysis from the aspects of raw materials, labor costs and depreciation. 2. Value and volume consumption status and trends of the market, including Global and Chinese top players’ capacity & pro
Published Date: Dec 2015
Published By: Gen Consulting

Price: $2800
Global Hepatitis A and B Combined Vaccine Market Report: 2016 Edition
This report delivers an extensive overview of Global Hepatitis A and B Combined Vaccine industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. It also helps the companies to better understand the trends of Soups market to seize opportunities and formulate crucial business strategies. With this report, you will get access to: 1. Market overview including definition, industrial chain (upstream & downstream), manufacturing technology details and the costs analysis from the aspects of raw materials, labor costs and depreciation. 2. Value and volume consumption status and trends of the market, including Global and Chinese top players’
Published Date: Dec 2015
Published By: Gen Consulting

Price: $2800
Hepatitis C - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H2 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Dec 2015
Published By: Global Markets Direct

Price: $2000
Global NASH (Non-Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs - Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market)
The Global NASH Market is growing at a moderate rate over last five years on account of rising number of obesity among young population. NASH (non-alcoholic steatohepatitis) is a large, un-tapped market with no FDA approved therapeutics. Antioxidants, anti-diabetic medications, anti-obesity medications and antihyper Lipidemics are some of the off-label products currently used by NASH patients. 
Published Date: Dec 2015
Published By: Azoth Analytics

Price: $2000
Hepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial regist
Published Date: Dec 2015
Published By: GlobalData

Price: $2500
United States Hepatitis Drugs Industry 2015 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Dec 2015
Published By: QYResearch

Price: $3800
EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024
Summary The Hepatitis B Virus (HBV) can cause both acute and chronic liver disease. HBV is typically transmitted through contact with infectious blood or bodily fluid, including vertical transmission from mother to child at birth and transmission via sexual intercourse. Risk factors of chronic hepatitis B (CHB) include unprotected sex with an infected partner, men who have sex with men (MSM), intravenous drug injection (IDU), and a previous history of a sexually transmitted disease (STD). CHB has a well-established comorbidity association with hepatitis C virus (HCV) infection, hepatitis D virus (HDV) infection, human immunodeficiency virus (HIV) infection, and alcohol abuse. The disease often starts as asymptomatic in the acute infection phase, with symptoms beginning to present 30 to
Published Date: Dec 2015
Published By: GlobalData

Price: $3995
Global Hepatitis Drugs Industry 2015 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Hepatitis Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Published Date: Dec 2015
Published By: QYResearch

Price: $2800
Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalDatas clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Alcoholic Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Alcoholic Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ di
Published Date: Dec 2015
Published By: GlobalData

Price: $2500
Steatohepatitis Global Clinical Trials Review, H2, 2015
Summary GlobalDatas clinical trial report, “Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Steatohepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clin
Published Date: Dec 2015
Published By: GlobalData

Price: $2500
Global Hepatitis Drugs Market 2015-2019
Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections. Technavio's analysts forecast the global hepatitis drugs market to grow at a CAGR of 17.1% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global hepatitis drugs market for the period 2015-2019
Published Date: Dec 2015
Published By: Technavio

Price: $3000
Global Hepatitis A Vaccine Sales 2015 Market Research Report
The report provides a basic overview of the Hepatitis A Vaccine industry including definitions, classifications, applications and industry chain structure. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report then analyzes the global Hepatitis A Vaccine market size (volume and value), and the sales segment market is also discussed by product type, application and region. The major Hepatitis A Vaccine market (including USA, Europe, China, Japan, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and application. Then we forecast the 2016-2021
Published Date: Dec 2015
Published By: QYResearch

Price: $4000
United States Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report
The United States Prophylactic Hepatitis B Virus Vaccines Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Prophylactic Hepatitis B Virus Vaccines industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prophylactic Hepatitis B Virus Vaccines market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margi
Published Date: Dec 2015
Published By: QYResearch

Price: $3800
Hepatitis D - Pipeline Review, H2 2015
Summary Global Markets Direct’s, ‘Hepatitis D - Pipeline Review, H2 2015’, provides an overview of the Hepatitis D’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hepatitis D, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis D and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Nov 2015
Published By: Global Markets Direct

Price: $2000